Omega-3 polyunsaturated fatty acids: The way forward in times of mixed evidence

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Weylandt, Karsten H ^a   Serini, Simona ^b   Chen, Yong Q ^c,d   Su, Hui Min ^e   Lim, Kyu ^f   Cittadini, Achille ^b   Calviello, Gabriella ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CATHOLIC UNIVERSITY   (Italy)

^c JIANGNAN UNIVERSITY   (China)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 4; CASPASE 7; CYTOSINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE REGULATED PROTEIN 78; HISTONE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; OMEGA 3 FATTY ACID; RAS PROTEIN; UNTRANSLATED RNA; FISH OIL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CELL MEMBRANE; CLINICAL TRIAL (TOPIC); COLON CANCER; DIMERIZATION; DNA METHYLATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FAT INTAKE; GENE EXPRESSION; HEART PROTECTION; HISTONE MODIFICATION; HUMAN; INFLAMMATORY DISEASE; INTERNALIZATION; LIPID RAFT; META ANALYSIS (TOPIC); METABOLIC DISORDER; MULTICENTER STUDY (TOPIC); NEOPLASM; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; CARDIOVASCULAR DISEASES; DIET; DIET THERAPY; METABOLISM; OBESITY; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DIET; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; OBESITY; RISK FACTORS;

EID: 84939629193     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/143109     Document Type: Review

References (229)

1. W. S. Harris, T. D. Dayspring, and T. J. Moran, "Omega-3 fatty acids and cardiovascular disease: new developments and applications, " PostgraduateMedicine, vol. 125, no. 6, pp. 100-113, 2013.
2. D. Kromhout and J. de Goede, "Update on cardiometabolic health effects of ω-3 fatty acids, " Current Opinion in Lipidology, vol. 25, no. 1, pp. 85-90, 2014.
3. G. Calviello, S. Serini, and E. Piccioni, "Alzheimers disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved, " Current Signal Transduction Therapy, vol. 3, no. 3, pp. 152-157, 2008.
4. C. I. F. Janssen and A. J. Kiliaan, "Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration, " Progress in Lipid Research, vol. 53, no. 1, pp. 1-17, 2014.
5. G. Young and J. Conquer, "Omega-3 fatty acids and neuropsychiatric disorders, " Reproduction Nutrition Development, vol. 45, no. 1, pp. 1-28, 2005.
6. R. M. Ortega, E. Rodríguez-Rodríguez, and A. M. López-Sobaler, "Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders, " British Journal of Nutrition, vol. 107, supplement 2, pp. S261-S270, 2012.
7. P. C. Calder, "Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1851, no. 4, pp. 469-484, 2015.
8. G. Calviello, S. Serini, and E. Piccioni, "n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved, " CurrentMedicinal Chemistry, vol. 14, no. 29, pp. 3059-3069, 2007.
9. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier, "Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth, " Progress in Lipid Research, vol. 49, no. 1, pp. 76-86, 2010.
10. Z. Gu, J. Suburu, H. Chen, and Y. Q. Chen, "Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention, " BioMed Research International, vol. 2013, Article ID 824563, 10 pages, 2013.
11. E. K. J. Pauwels and M. Kostkiewicz, "Fatty acid facts, part III: cardiovascular disease, or, a fish diet is not fishy, " DrugNews and Perspectives, vol. 21, no. 10, pp. 552-561, 2008.
12. G. P. Eckert, U. Lipka, and W. E. Muller, "Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 88, no. 1, pp. 105-114, 2013.
13. J. X. Kang and K. H. Weylandt, "Modulation of inflammatory cytokines by omega-3 fatty acids, " Sub-Cellular Biochemistry, vol. 49, pp. 133-143, 2008.
14. T. A. Babcock, T. Dekoj, and N. J. Espat, "Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes, " Nutrition in Clinical Practice, vol. 20, no. 1, pp. 62-74, 2005.
15. G. Calviello, S. Serini, and P. Palozza, "n-3 Polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer, " Current Signal Transduction Therapy, vol. 1, no. 3, pp. 255-271, 2006.
16. C. Boudrault, R. P. Bazinet, and D. W. L. Ma, "Experimental models and mechanisms underlying the protective effects of n-polyunsaturated fatty acids in Alzheimers disease, " Journal of Nutritional Biochemistry, vol. 20, no. 1, pp. 1-10, 2009.
17. R. Liperoti, F. Landi, O. Fusco, R. Bernabei, and G. Onder, "Omega-3 polyunsaturated fatty acids and depression: a review of the evidence, " Current Pharmaceutical Design, vol. 15, no. 36, pp. 4165-4172, 2009.
18. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto miocardico), "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto miocardico, " The Lancet, vol. 354, no. 9177, pp. 447-455, 1999.
19. P. Vitello, Alexander Leaf Dies at 92; Linked Diet and Health, New York Times, 2013.
20. G. DeMaria, "Omega-3. An overview. Focus on omega-3, " Agro Food Industry Hi-Tech, vol. 19, supplement, pp. 4-9, 2008.
21. D. Kromhout, E. J. Giltay, and J. M. Geleijnse, "n-3 fatty acids and cardiovascular events aftermyocardial infarction, " The New England Journal of Medicine, vol. 363, no. 21, pp. 2015-2026, 2010.
22. S. M. Kwak, S.-K. Myung, Y. J. Lee, and H. G. Seo, "Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials, " Archives of Internal Medicine, vol. 172, no. 9, pp. 686-694, 2012.
23. J. Bosch, H. C. Gerstein, G. R. Dagenais et al., "n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia, " The New England Journal of Medicine, vol. 367, no. 4, pp. 309-318, 2012.
24. J. G. Fodor, E. Helis, N. Yazdekhasti, and B. Vohnout, "Fishing for the origins of the Eskimos and heart disease story: facts or wishful thinking?" Canadian Journal of Cardiology, vol. 30, no. 8, pp. 864-868, 2014.
25. T. M. Brasky, A. K. Darke, X. Song et al., "Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 105, no. 15, pp. 1132-1141, 2013.
26. S. Serini, E. Fasano, E. Piccioni, A. R. M. Cittadini, and G. Calviello, "Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects, " Chemical Research in Toxicology, vol. 24, no. 12, pp. 2093-2105, 2011.
27. J. Suburu, K. Lim, G. Calviello, and Y. Q. Chen, "RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju023, 2014.
28. R. T. Holman, S. B. Johnson, and T. F. Hatch, "A case of human linolenic acid deficiency involving neurological abnormalities, " TheAmerican Journal of ClinicalNutrition, vol. 35, no. 3, pp. 617-623, 1982.
29. L. M. Arterburn, E. B. Hall, and H. Oken, "Distribution, interconversion, and dose response of n-3 fatty acids in humans, " American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1467S-1476S, 2006.
30. A. H. Stark, M. A. Crawford, and R. Reifen, "Update on alphalinolenic acid, " Nutrition Reviews, vol. 66, no. 6, pp. 326-332, 2008.
31. K. Jing, T. Wu, and K. Lim, "Omega-3 polyunsaturated fatty acids and cancer, " Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 8, pp. 1162-1177, 2013.
32. G. C. Burdge, "Metabolism of α-linolenic acid in humans, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 3, pp. 161-168, 2006.
33. R. T. Holman, "The slow discovery of the importance of ω3 essential fatty acids in human health, " The Journal of Nutrition, vol. 128, no. 2, supplement, pp. 427S-433S, 1998.
34. S. A. Scholtz, J. Colombo, and S. E. Carlson, "Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period, " NestlèNutrition InstituteWorkshop Series, vol. 77, pp. 145-154, 2013.
35. E. N. Smit, F. A. J. Muskiet, and E. R. Boersma, "Thepossible role of essential fatty acids in the pathophysiology of malnutrition: a review, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 4, pp. 241-250, 2004.
36. D. F. Horrobin, "Essential fatty acid metabolism and its modification in atopic eczema, " The American Journal of Clinical Nutrition, vol. 71, supplement 1, pp. 367S-372S, 2000.
37. A. P. Simopoulos, "Human requirement for N-3 polyunsaturated fatty acids, " Poultry Science, vol. 79, no. 7, pp. 961-970, 2000.
38. FAO-WHO, Fats and Fatty Acids in Human Nutrition: Report of an Expert Consultation, FAO Food and Nutrition Paper # 91, FAO, WHO, Geneva, Switzerland, 2010.
39. International Society for the Study of Fatty Acids and Lipids (ISSFAL), Report of the Sub-Committee on: Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults, International Society for the Study of Fatty Acids and Lipids (ISSFAL), 2004.
40. A. F. Luzzi and W. P. T. James, "European diet and public health: the continuing challenge, " PublicHealthNutrition, vol. 4, no. 2A, pp. 275-292, 2001.
41. B. Koletzko, E. Lien, C. Agostoni et al., "The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: reviewof current knowledge and consensus recommendations, " Journal of Perinatal Medicine, vol. 36, no. 1, pp. 5-14, 2008.
42. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA), "Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol, " The EFSA Journal, vol. 8, no. 3, article 1461, 2010.
43. The Scientific Advisory Committee on Nutrition and Committee on Toxicity Advice on Benefits and Risks Related to Fish Consumption, SACN Advice on Fish Consumption: Benefits and Risks, The Scientific Advisory Committee on Nutrition and Committee on Toxicity Advice on Benefits and Risks Related to Fish Consumption, 2004.
44. Health Council of the Netherlands, Guidelines for a Healthy Diet 2006, Publication no. 2006/21E, Health Council of the Netherlands, The Hague, the Netherlands, 2006.
45. Health Council of the Netherlands, Dietary Reference Intakes: Energy, Proteins, Fats, and Digestible Carbohydrates, Health Council of the Netherlands, The Hague, The Netherlands, 2001, (Corrected Edition: June 2002).
46. AFSSA, Apports nutritionnels conseillés pour la population francaise, Tec & Doc Lavoisier Editions, 3rd edition, 2001.
47. Conseil Supérieur de la Santé, Recommandations nutritionnelles pour la Belgique, Revision 2009, Publication du Conseil Superieur de la Sante no. 8 8309, Conseil Supérieur de la Santé, Brussels, Belgium, 2009.
48. Sociedad Española de Nutrición Comunitaria (SENC), "Objetivos nutricionales para la población española, " Revista Española de Nutrición Comunitaria, vol. 17, no. 4, pp. 178-199, 2011.
49. National Health and Medical Research Council and Department of Health and Ageing, Nutrient Reference Values for AustraliaandNewZealand IncludingRecommendedDietary Intakes, Commonwealth of Australia, Canberra, Australia, 2006.
50. Institute of Medicine, Food and Nutrition Board, Panel on Macronutrients, Panel on the Definition of Dietary Fiber, Subcommittee on Upper Reference Levels of Nutrients, Subcommittee on Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, DRI Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids, Washington, DC, USA, The National Academies Press, 2005.
51. J. P. Bantle, J. Wylie-Rosett, and A. L. Albright, "Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association, " Diabetes Care, vol. 31, supplement 1, pp. S61-S78, 2007.
52. P. M. Kris-Etherton, S. Innis, Ammerican Dietetic Assocition, and Dietitians of Canada, "Position of the American dietetic association and dietitians of Canada: dietary fatty acids, " The Journal of the American Dietetic Association, vol. 107, no. 9, pp. 1599-1611, 2007.
53. W. S. Harris, D. Mozaffarian, E. Rimm et al., "Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, andMetabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention, " Circulation, vol. 119, no. 6, pp. 902-907, 2009.
54. A. Leaf, C. M. Albert, M. Josephson et al., "Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake, " Circulation, vol. 112, no. 18, pp. 2762-2768, 2005.
55. L. Tavazzi, A. P. Maggioni, R. Marchioli et al., "Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial, " The Lancet, vol. 372, no. 9645, pp. 1223-1230, 2008.
56. P. Galan, E. Kesse-Guyot, S. Czernichow et al., "Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial, " The British Medical Journal, vol. 341, Article IDc6273, 2010.
57. M. Yokoyama, H. Origasa, M. Matsuzaki et al., "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, " The Lancet, vol. 369, no. 9567, pp. 1090-1098, 2007.
58. B. Rauch, R. Schiele, S. Schneider et al., "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guidelineadjusted therapy after myocardial infarction, " Circulation, vol. 122, no. 21, pp. 2152-2159, 2010.
59. M. H. Raitt, W. E. Connor, C. Morris et al., "Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial, " The Journal of the American Medical Association, vol. 293, no. 23, pp. 2884-2891, 2005.
60. I. A. Brouwer, P. L. Zock, A. J. Camm et al., "Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-Fatty acids and ventricular Arrhythmia (SOFA) randomized trial, " The Journal of the AmericanMedical Association, vol. 295, no. 22, pp. 2613-2619, 2006.
61. R. Chowdhury, S. Warnakula, S. Kunutsor et al., "Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis, " Annals of Internal Medicine, vol. 160, no. 6, pp. 398-406, 2014.
62. E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, "Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis, " The Journal of the American Medical Association, vol. 308, no. 10, pp. 1024-1033, 2012.
63. A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi, and M. Miglioli, "Effect of an enteric-coated fish-oil preparation on relapses in Crohns disease, " The New England Journal of Medicine, vol. 334, no. 24, pp. 1557-1560, 1996.
64. E. Scorletti, L. Bhatia, K. G. McCormick et al., "Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome study, " Hepatology, vol. 60, no. 4, pp. 1211-1221, 2014.
65. B. G. Feagan, W. J. Sandborn, U. Mittmann et al., "Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials, " Journal of the American Medical Association, vol. 299, no. 14, pp. 1690-1697, 2008.
66. W. F. Stenson, D. Cort, J. Rodgers et al., "Dietary supplementation with fish oil in ulcerative colitis, " Annals of Internal Medicine, vol. 116, no. 8, pp. 609-614, 1992.
67. N. Lasztity, J. Hamvas, L. Biró et al., "Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis-a prospective randomized clinical trial, " Clinical Nutrition, vol. 24, no. 2, pp. 198-205, 2005.
68. E. Cabré, M. Mañosa, and M. A. Gassull, "Omega-3 fatty acids and inflammatory bowel diseases-a systematic review, " British Journal of Nutrition, vol. 107, no. 2, pp. S240-S252, 2012.
69. J. Dyerberg, H. O. Bang, E. Stoffersen, S. Moncada, and J. R. Vane, "Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?" The Lancet, vol. 2, no. 8081, pp. 117-119, 1978.
70. J. X. Kang and A. Leaf, "Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiacmyocytes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9886-9890, 1994.
71. K. H. Weylandt, J. X. Kang, and A. Leaf, "Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids, " Lipids, vol. 31, no. 9, pp. 977-982, 1996.
72. G. E. Billman, J. X. Kang, and A. Leaf, "Prevention of ischemiainduced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs, " Lipids, vol. 32, no. 11, pp. 1161-1168, 1997.
73. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, " Circulation, vol. 106, no. 21, pp. 2747-2757, 2002.
74. G. Taubes, "The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes, " British Medical Journal, vol. 346, no. 7904, Article IDf1050, 2013.
75. W. S. Harris and G. C. Shearer, "Omega-6 fatty acids and cardiovascular disease: friend or foe?" Circulation, 2014.
76. M. de Lorgeril, P. Salen, P. Defaye, and M. Rabaeus, "Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?" BMC Medicine, vol. 11, no. 1, article 5, 2013.
77. W. S. Harris and C. von Schacky, "The Omega-3 Index: a new risk factor for death from coronary heart disease?" Preventive Medicine, vol. 39, no. 1, pp. 212-220, 2004.
78. W. S. Harris, "The omega-3 index as a risk factor for coronary heart disease, " The American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1997S-2002S, 2008.
79. K. H. Weylandt, C.-Y. Chiu, B. Gomolka, S. F. Waechter, and B. Wiedenmann, "Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation, " Prostaglandins & Other LipidMediators, vol. 97, no. 3-4, pp. 73-82, 2012.
80. J. R. Falck, G. Wallukat, N. Puli et al., "17(R), 18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues, " Journal ofMedicinal Chemistry, vol. 54, no. 12, pp. 4109-4118, 2011.
81. J. Endo, M. Sano, Y. Isobe et al., "18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling, " Journal of Experimental Medicine, vol. 211, no. 8, pp. 1673-1687, 2014.
82. M. Anti, G. Marra, F. Armelao et al., "Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer, " Gastroenterology, vol. 103, no. 3, pp. 883-891, 1992.
83. H.-P. Bartram, A. Gostner, W. Scheppach et al., "Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects, " Gastroenterology, vol. 105, no. 5, pp. 1317-1322, 1993.
84. M. Anti, F. Armelao, G. Marra et al., "Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas, " Gastroenterology, vol. 107, no. 6, pp. 1709-1718, 1994.
85. H.-P. Bartram, A. Gostner, B. S. Reddy et al., "Missing antiproliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio, " European Journal of Cancer Prevention, vol. 4, no. 3, pp. 231-237, 1995.
86. Y.-C. Huang, J. M. Jessup, R. A. Forse et al., "n-3 Fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa, " Lipids, vol. 31, no. 3, supplement, pp. S313-S317, 1996.
87. J. M. Gee, M. Watson, J. A. Matthew et al., "Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics, " The Journal of Nutrition, vol. 129, no. 10, pp. 1862-1865, 1999.
88. J. Cheng, K. Ogawa, K. Kuriki et al., "Increased intake of n-polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors, " Cancer Letters, vol. 193, no. 1, pp. 17-24, 2003.
89. E. D. Courtney, S. Matthews, C. Finlayson et al., "Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas, " International Journal of Colorectal Disease, vol. 22, no. 7, pp. 765-776, 2007.
90. N. J. West, S. K. Clark, R. K. S. Phillips et al., "Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis, " Gut, vol. 59, no. 7, pp. 918-925, 2010.
91. A. J. Cockbain, M. Volpato, A. D. Race et al., "Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid, " Gut, vol. 63, no. 11, pp. 1760-1768, 2014.
92. G. K. Pot, G. Majsak-Newman, A. Geelen et al., "Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial, " The American Journal of Clinical Nutrition, vol. 90, no. 2, pp. 354-361, 2009.
93. G. K. Pot, A. Geelen, G. Majsak-Newman et al., "Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies, " Journal of Nutrition, vol. 140, no. 2, pp. 371-376, 2010.
94. M. C. Mocellin, J. D. A. Pastore E Silva, C. D. Q. Camargo et al., "Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients, " Lipids, vol. 48, no. 9, pp. 879-888, 2013.
95. H. J. Murff, M. J. Shrubsole, Q. Cai et al., "Dietary intake of PUFAs and colorectal polyp risk, " The American Journal of Clinical Nutrition, vol. 95, no. 3, pp. 703-712, 2012.
96. E. D. Kantor, J. W. Lampe, U. Peters, T. L. Vaughan, and E. White, "Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer, " Nutrition and Cancer, vol. 66, no. 4, pp. 716-727, 2014.
97. M. Song, A. T. Chan, C. S. Fuchs et al., "Dietary intake of fish, ω-and ω-6 fatty acids and risk of colorectal cancer: a prospective study in U. S. men and women, " International Journal of Cancer, vol. 135, no. 10, pp. 2413-2423, 2014.
98. N. Habermann, C. M. Ulrich, A. Lundgreen et al., "PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer, " Genes and Nutrition, vol. 8, no. 1, pp. 115-126, 2013.
99. S. Wu, B. Feng, K. Li et al., "Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis, " The American Journal of Medicine, vol. 125, no. 6, pp. 551-559, 2012.
100. M. Gerber, "Background review paper on total fat, fatty acid intake and cancers, " Annals of Nutrition and Metabolism, vol. 55, no. 1-3, pp. 140-161, 2009.
101. M. Gerber, "Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies, " British Journal of Nutrition, vol. 107, no. 2, pp. S228-S239, 2012.
102. K. Mina, L. Fritschi, K. C. Johnson et al., "An inverse association between preserved fish and prostate cancer: results from a population-based case-control study in Canada, " Nutrition and Cancer, vol. 60, no. 2, pp. 222-226, 2008.
103. C. D. Williams, B. M. Whitley, C. Hoyo et al., "A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer, " Nutrition Research, vol. 31, no. 1, pp. 1-8, 2011.
104. F. L. Crowe, N. E. Allen, P. N. Appleby et al., "Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition, " The American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1353-1363, 2008.
105. V. Fradet, L. Cheng, G. Casey, and J. S. Witte, "Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk, " Clinical Cancer Research, vol. 15, no. 7, pp. 2559-2566, 2009.
106. A. R. Kristal, J. H. Cohen, P. Qu, and J. L. Stanford, "Associations of energy, fat, calcium, and vitaminDwith prostate cancer risk, " Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 8, pp. 719-725, 2002.
107. J. E. Chavarro, M. J. Stampfer, M. N. Hall, H. D. Sesso, and J. Ma, "A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality, " The American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1297-1303, 2008.
108. S.-Y. Park, L. R. Wilkens, S. M. Henning et al., "Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort, " Cancer Causes and Control, vol. 20, no. 2, pp. 211-223, 2009.
109. J. E. Torfadottir, U. A. Valdimarsdottir, L. A. Mucci et al., "Consumption of fish products across the lifespan and prostate cancer risk, " PLoS ONE, vol. 8, no. 4, Article ID e59799, 2013.
110. S. Männistö, P. Pietinen, M. J. Virtanen et al., "Fatty acids and risk of prostate cancer in a nested case-control study in male smokers, " Cancer Epidemiology, Biomarkers and Prevention, vol. 12, no. 12, pp. 1422-1428, 2003.
111. M. E. Chua, M. C. D. Sio, M. C. Sorongon, and M. L. Morales Jr., "The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a metaanalysis, " Canadian Urological Association Journal, vol. 7, no. 5-6, pp. E333-E343, 2013.
112. M. K. Sorongon-Legaspi, M. Chua, M. C. Sio, and M. Morales, "Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer, " Prostate Cancer, vol. 2013, Article ID 875615, 15 pages, 2013.
113. D. Patel, K. Thevenet-Morrison, and E. van Wijngaarden, "Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: results from the 2003 to 2010 national health and examination survey, " Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 91, no. 4, pp. 155-160, 2014.
114. S. Harvei, K. S. Bjerve, S. Tretli, E. Jellum, T. E. Robsahm, and L. Vatten, "Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer, " International Journal of Cancer, vol. 71, no. 4, pp. 545-551, 1997.
115. K. M. Szymanski, D. C. Wheeler, and L. A. Mucci, "Fish consumption and prostate cancer risk: a review and metaanalysis, " The American Journal of Clinical Nutrition, vol. 92, no. 5, pp. 1223-1233, 2010.
116. I. A. Brouwer, "Omega-3 PUFA: good or bad for prostate cancer?" Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 79, no. 3-5, pp. 97-99, 2008.
117. B. Samuelsson, "Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles, " Harvey Lectures, vol. 75, pp. 1-40, 1979.
118. S. Moncada, S. H. Ferreira, and J. R. Vane, "Prostaglandins, aspirin like drugs and the oedema of inflammation, " Nature, vol. 246, no. 5430, pp. 217-219, 1973.
119. B. Gopinath, A. E. Buyken, V. M. Flood, M. Empson, E. Rochtchina, and P. Mitchell, "Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality, " The American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 1073-1079, 2011.
120. H. F. Turk, J. M. Monk, Y.-Y. Fan, E. S. Callaway, B. Weeks, and R. S. Chapkin, "Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing, " American Journal of Physiology-Cell Physiology, vol. 304, no. 9, pp. C905-C917, 2013.
121. C. V. Whiting, P. W. Bland, and J. F. Tarlton, "Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis, " Inflammatory Bowel Diseases, vol. 11, no. 4, pp. 340-349, 2005.
122. S. Ghosh, D. DeCoffe, K. Brown et al., "Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis, " PLoS ONE, vol. 8, no. 2, Article IDe55468, 2013.
123. F. G. Campos, D. L. Waitzberg, A. Habr-Gama et al., "Impact of parenteral n-3 fatty acids on experimental acute colitis, " British Journal of Nutrition, vol. 87, no. 1, pp. S83-S88, 2002.
124. J. I. Fenton, N. G. Hord, S. Ghosh, and E. A. Gurzell, "Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 89, no. 6, pp. 379-390, 2013.
125. H. Matsunaga, R. Hokari, C. Kurihara et al., "Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelialmyofibroblasts, " Inflammatory Bowel Diseases, vol. 14, no. 10, pp. 1348-1357, 2008.
126. H. L. Woodworth, S. J. McCaskey, D. M. Duriancik et al., "Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis, " Cancer Research, vol. 70, no. 20, pp. 7960-7969, 2010.
127. R. A. F. Hegazi, R. S. Saad, H. Mady, L. E. Matarese, S. OKeefe, and H. M. Kandil, "Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-knockout mice, " Nutrition, vol. 22, no. 3, pp. 275-282, 2006.
128. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, "Interleukin-10-deficient mice develop chronic enterocolitis, " Cell, vol. 75, no. 2, pp. 263-274, 1993.
129. R. S. Chapkin, L. A. Davidson, L. Ly, B. R. Weeks, J. R. Lupton, and D. N. McMurray, "Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer, " Journal of Nutrition, vol. 137, supplement 1, pp. 200S-204S, 2007.
130. J. X. Kang, J. Wang, L. Wu, and Z. B. Kang, "Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids, " Nature, vol. 427, no. 6974, p. 504, 2004.
131. C. A. Hudert, K. H. Weylandt, Y. Lu et al., "Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11276-11281, 2006.
132. J. M. Monk, Q. Jia, E. Callaway et al., "Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in fat-1 mice, " Journal of Nutrition, vol. 142, no. 1, pp. 117-124, 2012.
133. Q. Jia, J. R. Lupton, R. Smith et al., "Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice, " Cancer Research, vol. 68, no. 10, pp. 3985-3991, 2008.
134. J. Nowak, K. H. Weylandt, P. Habbel et al., "Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids, " Carcinogenesis, vol. 28, no. 9, pp. 1991-1995, 2007.
135. C. Schmöcker, K. H. Weylandt, L. Kahlke et al., "Omega-fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines, " Hepatology, vol. 45, no. 4, pp. 864-869, 2007.
136. K. H. Weylandt, A. Nadolny, L. Kahlke et al., "Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis, " Biochimica et Biophysica Acta -Molecular Basis of Disease, vol. 1782, no. 11, pp. 634-641, 2008.
137. H. Teague, C. J. Fhaner, M. Harris, D. M. Duriancik, G. E. Reid, and S. R. Shaikh, "N-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity, " Journal of Lipid Research, vol. 54, no. 11, pp. 3130-3138, 2013.
138. C. N. Serhan, S. Hong, K. Gronert et al., "Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals, " The Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025-1037, 2002.
139. M. Arita, F. Bianchini, J. Aliberti et al., "Stereochemical assignment, antiinflammatory properties, and receptor for the omega-lipid mediator resolvin E1, " The Journal of Experimental Medicine, vol. 201, no. 5, pp. 713-722, 2005.
140. C. Y. Chiu, B. Gomolka, C. Dierkes et al., "Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acidmodulatemacrophage function and alleviate experimental colitis, " Inflammation Research, vol. 61, no. 9, pp. 967-976, 2012.
141. T. Köhnke, B. Gomolka, S. Bilal et al., "Acetylsalicylic acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators, " BioMed Research International, vol. 2013, Article ID 748160, 10 pages, 2013.
142. K. H. Weylandt, L. F. Krause, B. Gomolka et al., "Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipidmediators and reduced TNF-α, " Carcinogenesis, vol. 32, no. 6, pp. 897-903, 2011.
143. A. F. Bento, R. F. Claudino, R. C. Dutra, R. Marcon, and J. B. Calixto, "Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice, " Journal of Immunology, vol. 187, no. 4, pp. 1957-1969, 2011.
144. A. González-Périz, A. Planagumà, K. Gronert et al., "Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA, " The FASEB Journal, vol. 20, no. 14, pp. 2537-2539, 2006.
145. A. Neuhofer, M. Zeyda, D. Mascher et al., "Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation, " Diabetes, vol. 62, no. 6, pp. 1945-1956, 2013.
146. A. Ariel and C. N. Serhan, "Resolvins and protectins in the termination program of acute inflammation, " Trends in Immunology, vol. 28, no. 4, pp. 176-183, 2007.
147. J. Griffitts, D. Saunders, Y. A. Tesiram et al., "Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model. Omega-3 fatty acids prevent liver neoplasia, " Biochimica et Biophysica Acta, vol. 1801, no. 10, pp. 1133-1144, 2010.
148. K. Lim, C. Han, Y. Dai, M. Shen, and T. Wu, "Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2, " Molecular CancerTherapeutics, vol. 8, no. 11, pp. 3046-3055, 2009.
149. N. Sawada, M. Inoue, M. Iwasaki et al., "Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma, " Gastroenterology, vol. 142, no. 7, pp. 1468-1475, 2012.
150. J. A. Baron, B. F. Cole, R. S. Sandler et al., "A randomized trial of aspirin to prevent colorectal adenomas, " The New England Journal of Medicine, vol. 348, no. 10, pp. 891-899, 2003.
151. P. M. Rothwell, M. Wilson, C. E. Elwin et al., "Long-term effect of aspirin on colorectal cancer incidence andmortality: 20-year follow-up of five randomised trials, " The Lancet, vol. 376, no. 9754, pp. 1741-1750, 2010.
152. M. A. Hull, A. C. Sandell, A. A. Montgomery et al., "A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial, " Trials, vol. 14, no. 1, article 237, 2013.
153. S. Serini, E. Piccioni, and G. Calviello, "ω-3 PUFAs and colon cancer: experimental studies and human interventional trials, " in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello and S. Serini, Eds., vol. 1 of Diet and Cancer, pp. 67-89, Springer, Dordrecht, The Netherlands, 2010.
154. S. Serini, E. Fasano, E. Piccioni, A. R. M. Cittadini, and G. Calviello, "Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved, " Current Medicinal Chemistry, vol. 18, no. 26, pp. 4065-4075, 2011.
155. S. Serini, E. Fasano, L. Celleno, A. Cittadini, and G. Calviello, "Potential of long-chain n-3 polyunsaturated fatty acids in melanoma prevention, " Nutrition Reviews, vol. 72, no. 4, pp. 255-266, 2014.
156. K. Triff, E. Kim, and R. S. Chapkin, "Chemoprotective epigenetic mechanisms in a colorectal cancer model: modulation by n-3 PUFA in combination with fermentable fiber, " Current Pharmacology Reports, vol. 1, no. 1, pp. 11-20, 2015.
157. R. S. Chapkin, J. Seo, D. N. McMurray, and J. R. Lupton, "Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine, " Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 14-23, 2008.
158. R. S. Chapkin, V. DeClercq, E. Kim, N. R. Fuentes, and Y. Y. Fan, "Mechanisms by which pleiotropic amphiphilic n-3 PUFA reduce colon cancer risk, " Current Colorectal Cancer Reports, vol. 10, no. 4, pp. 442-452, 2014.
159. W. Stillwell and S. R. Wassall, "Docosahexaenoic acid: membrane properties of a unique fatty acid, " Chemistry and Physics of Lipids, vol. 126, no. 1, pp. 1-27, 2003.
160. E. Fasano, S. Serini, E. Piccioni et al., "DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines, " Biochimica et BiophysicaActa:Molecular Basis of Disease, vol. 1822, no. 11, pp. 1762-1772, 2012.
161. M. Ni, Y. Zhang, and A. S. Lee, "Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting, " Biochemical Journal, vol. 434, no. 2, pp. 181-188, 2011.
162. R. A. Siddiqui, K. Harvey, and W. Stillwell, "Anticancer properties of oxidation products of docosahexaenoic acid, " Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 47-56, 2008.
163. D.-S. Im, "Omega-3 fatty acids in anti-inflammation (proresolution) and GPCRs, " Progress in Lipid Research, vol. 51, no. 3, pp. 232-237, 2012.
164. P. C. Calder, "Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance, " Biochimica et Biophysica Acta, vol. 1851, no. 4, pp. 469-484, 2015.
165. N. Sadli, M. L. Ackland, D. de Mel, A. J. Sinclair, and C. Suphioglu, "Effects of zinc and DHA on the epigenetic regulation of human neuronal cells, " Cellular Physiology and Biochemistry, vol. 29, no. 1-2, pp. 87-98, 2012.
166. H.-S. Lee, A. Barraza-Villarreal, H. Hernandez-Vargas et al., "Modulation of DNA methylation states and infant immune system by dietary supplementation with 3 PUFA during pregnancy in an intervention study, " The American Journal of Clinical Nutrition, vol. 98, no. 2, pp. 480-487, 2013.
167. M. Amarasekera, P. Noakes, D. Strickland, R. Saffery, D. J. Martino, and S. L. Prescott, "Epigenome-wide analysis of neonatal CD4+ T-cell DNA methylation sites potentially affected by maternal fish oil supplementation, " Epigenetics, vol. 9, no. 12, pp. 1570-1576, 2014.
168. M. Dimri, P. V. Bommi, A. A. Sahasrabuddhe, J. D. Khandekar, and G. P. Dimri, "Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells, " Carcinogenesis, vol. 31, no. 3, pp. 489-495, 2010.
169. Y. Cho, N. D. Turner, L. A. Davidson, R. S. Chapkin, R. J. Carroll, and J. R. Lupton, "A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas, " Experimental Biology and Medicine, vol. 237, no. 12, pp. 1387-1393, 2012.
170. Y. Cho, N. D. Turner, L. A. Davidson, R. S. Chapkin, R. J. Carroll, and J. R. Lupton, "Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promotermethylation, " Experimental Biology and Medicine, vol. 239, no. 3, pp. 302-310, 2014.
171. A. J. Cockbain, G. J. Toogood, and M. A. Hull, "Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer, " Gut, vol. 61, no. 1, pp. 135-149, 2012.
172. A. Bommareddy, X. Zhang, D. Schrader et al., "Effects of dietary flaxseed on intestinal tumorigenesis in ApcMin mouse, " Nutrition and Cancer, vol. 61, no. 2, pp. 276-283, 2009.
173. G. Piazzi, G. DArgenio, A. Prossomariti et al., "Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer actingonNotch signaling and gut microbiota, " International Journal of Cancer, vol. 135, no. 9, pp. 2004-2013, 2014.
174. P. Griffini, O. Fehres, L. Klieverik et al., "Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver, " Cancer Research, vol. 58, no. 15, pp. 3312-3319, 1998.
175. T. Yang, S. Fang, H.-X. Zhang et al., "N-3PUFAshave antiproliferative and apoptotic effects on human colorectal cancer stemlike cells in vitro, " Journal of Nutritional Biochemistry, vol. 24, no. 5, pp. 744-753, 2013.
176. F. de Carlo, T. R. Witte, W. E. Hardman, and P. P. Claudio, "Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy, " PLoS ONE, vol. 8, no. 7, Article IDe69760, 2013.
177. A. Vasudevan, Y. Yu, S. Banerjee et al., "Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer, " Cancer Prevention Research, vol. 7, no. 11, pp. 1138-1148, 2014.
178. A. Zeuner, M. Todaro, G. Stassi, and R. De Maria, "Colorectal cancer stem cells: from the crypt to the clinic, " Cell Stem Cell, vol. 15, no. 6, pp. 692-705, 2014.
179. N. Barker, J. H. van Es, J. Kuipers et al., "Identification of stem cells in small intestine and colon by marker gene Lgr5, " Nature, vol. 449, no. 7165, pp. 1003-1007, 2007.
180. P. Dalerba, S. J. Dylla, I. K. Park et al., "Phenotypic characterization of human colorectal cancer stem cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 24, pp. 10158-10163, 2007.
181. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi et al., "Identification and expansion of human colon-cancer-initiating cells, " Nature, vol. 445, no. 7123, pp. 111-115, 2007.
182. P. D. Biondo, D. N. Brindley, M. B. Sawyer, and C. J. Field, "The potential for treatmentwith dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy, " Journal of Nutritional Biochemistry, vol. 19, no. 12, pp. 787-796, 2008.
183. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, "Antineoplastic effects ofN-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies, " Nutrition and Cancer, vol. 61, no. 3, pp. 287-301, 2009.
184. J. Wang, T. Luo, S. Li, and J. Zhao, "The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs, " Expert Opinion on Drug Delivery, vol. 9, no. 1, pp. 1-7, 2012.
185. G. Calviello, P. Palozza, P. Franceschelli, and G. M. Bartoli, "Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues, " Lipids, vol. 32, no. 10, pp. 1075-1083, 1997.
186. S. S. Taneja, "Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " The Journal of Urology, vol. 191, no. 3, p. 658, 2014.
187. K. El-Bayoumy, H. Thompson, and A. Manni, "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju017, 2014.
188. J. T. Brenna, G. C. Burdge, M. A. Crawford et al., "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju015, 2014.
189. M. McCulloch, E. Alvarez, R. Gendreau, S. Haney, J. Harrelson, and R. Luo, "RE: serum phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju024, 2014.
190. W. S. Harris and M. H. Davidson, "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of theNational Cancer Institute, vol. 106, no. 4, Article IDdju019, 2014.
191. J. E. Torfadottir, M. J. Stampfer, L. A. Mucci, and E. L. Giovannucci, "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju018, 2014.
192. M. F. McCarty, J. J. Dinicolantonio, C. J. Lavie, and J. H. OKeefe, "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article IDdju014, 2014.
193. L. G. Cleland, S. M. Proudman, and M. J. James, "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju022, 2014.
194. S. Tokudome, R. Ando, Y. Ichikawa et al., "RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju020, 2014.
195. P. O. Eser, J. P. Vanden Heuvel, J. Araujo, and J. T. Thompson, "Marine-and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation, " Molecular and Clinical Oncology, vol. 1, no. 3, pp. 444-452, 2013.
196. S. A. Apte, D. A. Cavazos, K. A. Whelan, and L. A. Degraffenried, "A low dietary ratio of omega-6 to omega-3 fatty acids may delay progression of prostate cancer, " Nutrition and Cancer, vol. 65, no. 4, pp. 556-562, 2013.
197. P. Astorg, "Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence, " Cancer Causes & Control, vol. 15, no. 4, pp. 367-386, 2004.
198. M. D. Brown, C. A. Hart, E. Gazi, S. Bagley, and N. W. Clarke, "Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega PUFAs, " British Journal of Cancer, vol. 94, no. 6, pp. 842-853, 2006.
199. D. Ruan and S. P. So, "Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo, " Life Sciences, vol. 116, no. 1, pp. 43-50, 2014.
200. S. Larré, N. Tran, C. Fan et al., "PGE2 and LTB4 tissue levels in benign and cancerous prostates, " Prostaglandins andOther Lipid Mediators, vol. 87, no. 1-4, pp. 14-19, 2008.
201. T. M. Brasky, C. Till, E. White et al., "Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial, " The American Journal of Epidemiology, vol. 173, no. 12, pp. 1429-1439, 2011.
202. R. Sosnowski and J. Zawistowski, "Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " European Urology, vol. 65, no. 5, p. 1012, 2014.
203. K. Chow and D. G. Murphy, "Words of wisdom. Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial, " European Urology, vol. 64, no. 6, pp. 1015-1016, 2013.
204. V. Kipnis, A. F. Subar, D. Midthune et al., "Structure of dietary measurement error: results of the OPEN biomarker study, " American Journal of Epidemiology, vol. 158, no. 1, pp. 14-21, 2003.
205. D. J. Hunter, E. B. Rimm, F. M. Sacks et al., "Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men, " The American Journal of Epidemiology, vol. 135, no. 4, pp. 418-427, 1992.
206. Y. Kimura, "ω-3 PUFAs and colon cancer: epidemiological studies, " in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello and S. Serini, Eds., pp. 41-66, Springer, Dordrecht, The Netherlands, 2010.
207. K. Wakai, Y. Ito, M. Kojima et al., "Intake frequency of fish and serum levels of long-chain n-3 fatty acids: a cross-sectional study within the Japan Collaborative Cohort Study, " Journal of Epidemiology, vol. 15, no. 6, pp. 211-218, 2005.
208. L. K. Dennis, L. G. Snetselaar, B. J. Smith, R. E. Stewart, and M. E. C. Robbins, "Problems with the assessment of dietary fat in prostate cancer studies, " American Journal of Epidemiology, vol. 160, no. 5, pp. 436-444, 2004.
209. L. Hodson, C. M. Skeaff, and B. A. Fielding, "Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake, " Progress in Lipid Research, vol. 47, no. 5, pp. 348-380, 2008.
210. N. C. Øverby, L. Serra-Majem, and L. F. Andersen, "Dietary assessment methods on n-3 fatty acid intake: a systematic review, "The British Journal of Nutrition, vol. 102, supplement 1, pp. S56-S63, 2009.
211. L. Dahl, C. A. Mæland, and T. Bjørkkjær, "A short food frequency questionnaire to assess intake of seafood and n-3 supplements: validation with biomarkers, " Nutrition Journal, vol. 10, no. 1, article 127, 2011.
212. W. S. Harris and R. M. Thomas, "Biological variability of blood omega-3 biomarkers, " Clinical Biochemistry, vol. 43, no. 3, pp. 338-340, 2010.
213. M. H. Davidson, J. Johnson, M. W. Rooney, M. L. Kyle, and D. F. Kling, "A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova compared to Lovaza in a pharmacokinetic singledose evaluation) study, " Journal of Clinical Lipidology, vol. 6, no. 6, pp. 573-584, 2012.
214. W. S. Harris, S. A. Varvel, J. V. Pottala, G. R. Warnick, and J. P. McConnell, "Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: implications for clinical utility, " Journal of Clinical Lipidology, vol. 7, no. 5, pp. 433-440, 2013.
215. E. Fasano, S. Serini, A. Cittadini, and G. Calviello, "Long-Chain n-3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans?" Critical Reviews in Food Science and Nutrition, 2015.
216. E. J. Freireich, E. A. Gehan, D. P. Rall, L. H. Schmidt, and H. E. Skipper, "Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man, " Cancer Chemotherapy Reports, vol. 50, no. 4, pp. 219-244, 1966.
217. P. Bougnoux, N. Hajjaji, M. N. Ferrasson, B. Giraudeau, C. Couet, and O. Le Floch, "Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial, " British Journal of Cancer, vol. 101, no. 12, pp. 1978-1985, 2009.
218. L. D. Yee, J. L. Lester, R. M. Cole et al., "ω-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition, " The American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1185-1194, 2010.
219. M. Yamashita, Y. Yamashita, T. Ando, J. Wakamiya, and S. Akiba, "Identification and determination of selenoneine, 2-selenyl-Nα, Nα, Nα-trimethyl-L-histidine, as the major organic selenium in blood cells in a fish-eating population on remote Japanese Islands, " Biological Trace Element Research, vol. 156, no. 1-3, pp. 36-44, 2013.
220. J. Dort, N. Leblanc, J. Maltais-Giguère, B. Liaset, C. H. Côté, and H. Jacques, "Beneficial effects of cod protein on inflammatory cell accumulation in rat skeletal muscle after injury are driven by its high levels of arginine, glycine, taurine and lysine, " PLoS ONE, vol. 8, no. 10, Article IDe77274, 2013.
221. R. Hosomi, M. Yoshida, and K. Fukunaga, "Seafood consumption and components for health, " Global Journal of Health Science, vol. 4, no. 3, pp. 72-86, 2012.
222. A. P. Simopoulos, "Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk, " Experimental Biology and Medicine, vol. 235, no. 7, pp. 785-795, 2010.
223. J. P. Vanden Heuvel, "Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids, " Progress in Molecular Biology and Translational Science, vol. 108, pp. 75-112, 2012.
224. M. Gago-Dominguez, J. E. Castelao, C.-L. Sun et al., "Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore, " Carcinogenesis, vol. 25, no. 11, pp. 2143-2147, 2004.
225. M. C. Stern, K. D. Siegmund, R. Corral, and R. W. Haile, "XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk, " Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 3, pp. 609-615, 2005.
226. E. M. Poole, J. Bigler, J. Whitton et al., "Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps, " Carcinogenesis, vol. 28, no. 6, pp. 1259-1263, 2007.
227. E. M. Poole, L. Hsu, L. Xiao et al., "Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma, " Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 2, pp. 547-557, 2010.
228. M. C. Stern, L. M. Butler, R. Corral et al., "Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study, " Journal ofNutrigenetics andNutrigenomics, vol. 2, no. 6, pp. 273-279, 2010.
229. S. R. Porenta, Y.-A. Ko, S. B. Gruber et al., "Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study, " Cancer Prevention Research, vol. 6, no. 11, pp. 1212-1221, 2013.